Study About Simvastatin in Portal Hypertension in Compensated Cirrhosis
Status:
Unknown status
Trial end date:
2015-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether simvastatin is effective in the prevention
of progression of porta hypertension in compensated cirrhosis patients.
Phase:
Phase 4
Details
Lead Sponsor:
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau